GC Latin America

GC Biopharma Latin America is the regional subsidiary of GC Biopharma, a leading South Korean biopharmaceutical company specializing in plasma-derived medicines and vaccines. Headquartered in Panama, the company serves as a strategic hub for the commercialization and distribution of specialized therapies across Latin American markets. Its core portfolio includes treatments for rare diseases, such as Hunterase for Hunter syndrome, as well as immunoglobulins and a variety of vaccines. The organization focuses on navigating regional regulatory landscapes to ensure patient access to high-quality biological products. By leveraging the parent company's manufacturing excellence, GC Biopharma Latin America works to expand its footprint in emerging markets. The company plays a critical role in the global supply chain for essential medicines in the immunology and infectious disease sectors.